While the compound attenuated the activation of Notch-1 in colon cancer and human breast cancer cells, it activates the cleavage of Notch-2 and Notch-4 in human breast cancer (MDA-MB-231) cells. This evidence concerns the gene NOTCH2 and breast carcinoma.